Compare · TMO vs VICR
TMO vs VICR
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Vicor Corporation (VICR): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VICR operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $226.94B, about 26.1x VICR ($8.69B).
- TMO has been more active in the news (13 items in the past 4 weeks vs 6 for VICR).
- TMO has more recent analyst coverage (25 ratings vs 13 for VICR).
- Company
- Thermo Fisher Scientific Inc
- Vicor Corporation
- Price
- -
- -
- Market cap
- $226.94B
- $8.69B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 13
- 6
- Recent ratings
- 25
- 13
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Vicor Corporation
Vicor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets modular power components and power systems for converting electrical power in the United States, Europe, the Asia Pacific, and internationally. The company offers a range of brick-format DC-DC converters; complementary components; and input and output voltage, and output power products, as well as electrical and mechanical accessories. It also provides custom power systems solutions. The company serves independent manufacturers of electronic devices, original equipment manufacturers, and their contract manufacturers in the aerospace and aviation, defense electronics, industrial automation and equipment, instrumentation, test equipment, solid state lighting, telecommunications and networking infrastructure, and vehicles and transportation markets. Vicor Corporation was founded in 1981 and is headquartered in Andover, Massachusetts.
Latest TMO
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $172,439 worth of shares (275 units at $627.05) as part of a pre-agreed trading plan (SEC Form 4)
Latest VICR
- Corp. VP-Global Sales & Mktg. Davies Philip D sold $546,084 worth of shares (3,073 units at $177.70) as part of a pre-agreed trading plan and exercised 3,073 shares at a strike of $41.61 (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Vicor Corporation
- SEC Form 8-K filed by Vicor Corporation
- Director Anderson Samuel J exercised 3,409 shares at a strike of $46.94, increasing direct ownership by 85% to 7,443 units (SEC Form 4)
- Director Lavie Zmira exercised 908 shares at a strike of $44.07 and sold $227,000 worth of shares (908 units at $250.00) (SEC Form 4)
- Director Anderson Samuel J sold $523,640 worth of shares (2,073 units at $252.60), decreasing direct ownership by 34% to 4,034 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Vicor Corporation
- Corp. VP-Global Sales & Mktg. Davies Philip D exercised 3,072 shares at a strike of $41.61 and sold $650,308 worth of shares (3,072 units at $211.69) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by Vicor Corporation
- Director Eichten Estia J exercised 5,987 shares at a strike of $33.42, increasing direct ownership by 6% to 104,825 units (SEC Form 4)